Boston Scientific Eyes Policy Catalyst For Farapulse Growth As ASC Reimbursement Approaches

Proposed CMS Reimbursement May Shift A Large Share Of AF Ablations To ASCs, Creating Both Capacity Relief And Competitive Advantage.

 
• By Shubham Singh
  
Sep 16, 2019 Fremont / CA / USA - Boston Scientific office buildings in Silicon Valley; Boston Scientific Corporation is a manufacturer of medical devices used in interventional medical specialties
Boston Scientific’s Farapulse pulsed field ablation (PFA) system continues to be a major growth driver, particularly as US procedural capacity constraints begin to ease. • Source: Shutterstock

More from Strategy

More from Business